Ferring in Denmark to launch newly-purchased cancer treatment in Europe

The pharmaceutical company Ferring has purchased rights to a phase-3 cancer treatment, which Ferring's Danish department will be working with in Europe. However, the acquisition does not mean that Ferring will become a cancer-focused firm, says Ferring's CEO in Denmark.

Ferring's department in Ørestad, Copenhagen in Denmark. Photo: Martin Havtorn Petersen/MedWatch

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

David Solomon lander nyt topjob

Mindre end tre måneder efter at være trådt tilbage som adm. direktør i amerikansk biotekselskab efter kontrovers om brug af et kreditkort er den tidligere Zealand Pharma-topchef David Solomon atter tilbage i direktørstolen. Denne gang i et britisk biotekselskab.

Related articles